Literature DB >> 15685372

Potential role of NO in modulation of COX-2 expression and PGE2 production in pancreatic beta-cells.

Jia-Jian Ling1, Yu-Jie Sun, Dong-Ya Zhu, Qi Chen, Xiao Han.   

Abstract

Cytokines have been implicated in pancreatic beta-cell destruction leading to type 1 diabetes. Exposure to interleukin-1beta (IL-1beta) of pancreatic beta-cells induces expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Subsequent formation of nitric oxide (NO) and prostaglandin E2 (PGE2) may impair beta-cell function. Using NOS inhibitor N(G)-monomethyl-L-arginine (L-NMMA), we have further investigated the relation between NO formation and COX-2 expression. IL-1beta stimulated the formation of NO and PGE2 by pancreatic beta-cells. L-NMMA completely inhibited IL-1beta-induced NO formation and attenuated PGE2 production. COX-2 gene transcription level and protein expression were determined by real-time PCR, Western blot and luciferase analysis. L-NMMA inhibited IL-1beta-induced promoter activity, gene transcription and protein expression of COX-2 in pancreatic beta-cells. Therefore, we concluded that NO-affected COX-2 activity is directly linked to COX-2 gene transcription and protein expression in pancreatic beta-cells. The identification of a novel interaction of NO on the COX signaling pathway in beta-cells provides a strategy of intervention for further evaluating the role of NO and PGE2 in autoimmune diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15685372

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  7 in total

1.  Prostaglandin E2 regulates Foxo activity via the Akt pathway: implications for pancreatic islet beta cell dysfunction.

Authors:  Z X Meng; J X Sun; J J Ling; J H Lv; D Y Zhu; Q Chen; Y J Sun; X Han
Journal:  Diabetologia       Date:  2006-10-11       Impact factor: 10.122

2.  Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down-regulation of mitogen-activated protein kinase-mediated nuclear factor-kappaB signaling.

Authors:  Niranjan Rajapakse; Moon-Moo Kim; Eresha Mendis; Se-Kwon Kim
Journal:  Immunology       Date:  2008-01-18       Impact factor: 7.397

3.  Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus.

Authors:  David Z I Cherney; Heather N Reich; Shan Jiang; Ronnie Har; Rania Nasrallah; Richard L Hébert; Vesta Lai; James W Scholey; Etienne B Sochett
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-01       Impact factor: 3.619

4.  Macrophage polarization is linked to Ca2+-independent phospholipase A2β-derived lipids and cross-cell signaling in mice.

Authors:  Alexander J Nelson; Daniel J Stephenson; Christopher L Cardona; Xiaoyong Lei; Abdulaziz Almutairi; Tayleur D White; Ying G Tusing; Margaret A Park; Suzanne E Barbour; Charles E Chalfant; Sasanka Ramanadham
Journal:  J Lipid Res       Date:  2019-12-09       Impact factor: 5.922

Review 5.  The Impact of the Ca2+-Independent Phospholipase A2β (iPLA2β) on Immune Cells.

Authors:  Tayleur D White; Abdulaziz Almutairi; Ying Gai Tusing; Xiaoyong Lei; Sasanka Ramanadham
Journal:  Biomolecules       Date:  2021-04-15

6.  Pentoxifylline decreases glycemia levels and TNF-alpha, iNOS and COX-2 expressions in diabetic rat pancreas.

Authors:  Francisca Adilfa O Garcia; Sofia F Pinto; Andrezza F Cavalcante; Lívia T Lucetti; Silvana Ms Menezes; Cícero Francisco B Felipe; Ana Paula Nn Alves; Gerly Anne C Brito; Gilberto S Cerqueira; Glauce Sb Viana
Journal:  Springerplus       Date:  2014-06-05

7.  Riboflavin along with antibiotics balances reactive oxygen species and inflammatory cytokines and controls Staphylococcus aureus infection by boosting murine macrophage function and regulates inflammation.

Authors:  Somrita Dey; Biswadev Bishayi
Journal:  J Inflamm (Lond)       Date:  2016-11-28       Impact factor: 4.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.